Suppr超能文献

线粒体功能障碍及其对糖尿病心脏的影响。

Mitochondrial dysfunction and its impact on diabetic heart.

机构信息

Center for Translational Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.

Center for Translational Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.

出版信息

Biochim Biophys Acta Mol Basis Dis. 2017 May;1863(5):1098-1105. doi: 10.1016/j.bbadis.2016.08.021. Epub 2016 Sep 1.

Abstract

Mitochondrial dysfunction and associated oxidative stress are strongly linked to cardiovascular, neurodegenerative, and age associated disorders. More specifically cardiovascular diseases are common in patients with diabetes and significant contributor to the high mortality rates associated with diabetes. Studies have shown that the heart failure risk is increased in diabetic patients even after adjusting for coronary artery disease and hypertension. Although the actual basis of the increased heart failure risk is multifactorial, increasing evidences suggest that imbalances in mitochondrial function and associated oxidative stress play an important role in this process. This review summarizes these abnormalities in mitochondrial function and discusses potential underlying mechanisms. This article is part of a Special Issue entitled: Oxidative Stress and Mitochondrial Quality in Diabetes/Obesity and Critical Illness Spectrum of Diseases - edited by P. Hemachandra Reddy.

摘要

线粒体功能障碍及相关氧化应激与心血管疾病、神经退行性疾病和与年龄相关的疾病密切相关。更具体地说,心血管疾病在糖尿病患者中很常见,是导致糖尿病高死亡率的重要因素。研究表明,即使在调整了冠状动脉疾病和高血压因素后,糖尿病患者的心力衰竭风险也会增加。虽然心力衰竭风险增加的实际基础是多因素的,但越来越多的证据表明,线粒体功能失衡和相关氧化应激在这一过程中起着重要作用。本综述总结了线粒体功能的这些异常,并讨论了潜在的潜在机制。本文是题为“糖尿病/肥胖和危重病谱疾病中的氧化应激和线粒体质量”特刊的一部分-由 P. Hemachandra Reddy 编辑。

相似文献

1
Mitochondrial dysfunction and its impact on diabetic heart.
Biochim Biophys Acta Mol Basis Dis. 2017 May;1863(5):1098-1105. doi: 10.1016/j.bbadis.2016.08.021. Epub 2016 Sep 1.
2
Mitochondrial dysfunction in diabetic cardiomyopathy.
Biochim Biophys Acta. 2011 Jul;1813(7):1351-9. doi: 10.1016/j.bbamcr.2011.01.014. Epub 2011 Jan 20.
3
Mitochondria in the diabetic heart.
Cardiovasc Res. 2010 Nov 1;88(2):229-40. doi: 10.1093/cvr/cvq239. Epub 2010 Jul 16.
6
The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise.
Antioxid Redox Signal. 2015 Jun 10;22(17):1515-26. doi: 10.1089/ars.2015.6294. Epub 2015 Apr 15.
7
Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.
Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt B):1949-1959. doi: 10.1016/j.bbadis.2017.10.035. Epub 2017 Nov 3.
8
Effect of exercise on improving myocardial mitochondrial function in decreasing diabetic cardiomyopathy.
Exp Physiol. 2024 Feb;109(2):190-201. doi: 10.1113/EP091309. Epub 2023 Oct 16.
9
Diabetes mellitus and myocardial mitochondrial dysfunction: bench to bedside.
Heart Fail Clin. 2012 Oct;8(4):551-61. doi: 10.1016/j.hfc.2012.06.001. Epub 2012 Aug 9.
10
Myocardial fatty acid metabolism and lipotoxicity in the setting of insulin resistance.
Heart Fail Clin. 2012 Oct;8(4):643-61. doi: 10.1016/j.hfc.2012.06.008. Epub 2012 Aug 9.

引用本文的文献

1
A robust method for assessing mitochondrial function in healthy and diseased frozen cardiac tissue.
Commun Biol. 2025 Aug 19;8(1):1249. doi: 10.1038/s42003-025-08608-5.
3
Interaction between post-tumor inflammation and vascular smooth muscle cell dysfunction in sepsis-induced cardiomyopathy.
Front Immunol. 2025 Apr 10;16:1560717. doi: 10.3389/fimmu.2025.1560717. eCollection 2025.
5
Role of Quercetin in Diabetic Cardiomyopathy.
Plants (Basel). 2024 Dec 25;14(1):25. doi: 10.3390/plants14010025.
6
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy.
Cardiovasc Diabetol. 2024 Dec 20;23(1):450. doi: 10.1186/s12933-024-02490-x.
8
Molecular Basis of Cardiomyopathies in Type 2 Diabetes.
Int J Mol Sci. 2024 Jul 29;25(15):8280. doi: 10.3390/ijms25158280.
9
SIRT6 in Regulation of Mitochondrial Damage and Associated Cardiac Dysfunctions: A Possible Therapeutic Target for CVDs.
Cardiovasc Toxicol. 2024 Jun;24(6):598-621. doi: 10.1007/s12012-024-09858-1. Epub 2024 Apr 30.
10
CAV3 alleviates diabetic cardiomyopathy via inhibiting NDUFA10-mediated mitochondrial dysfunction.
J Transl Med. 2024 Apr 26;22(1):390. doi: 10.1186/s12967-024-05223-6.

本文引用的文献

1
Evolving Challenges for Targeting Metabolic Abnormalities in Heart Failure.
JACC Heart Fail. 2016 Jul;4(7):567-569. doi: 10.1016/j.jchf.2016.03.008. Epub 2016 May 11.
3
Mitochondrial quality control in the diabetic heart.
J Mol Cell Cardiol. 2016 Jun;95:57-69. doi: 10.1016/j.yjmcc.2015.12.025. Epub 2015 Dec 29.
5
MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart.
Eur Heart J. 2016 Feb 7;37(6):572-6. doi: 10.1093/eurheartj/ehv599. Epub 2015 Nov 9.
7
Investigating the Mechanism of Hyperglycemia-Induced Fetal Cardiac Hypertrophy.
PLoS One. 2015 Sep 29;10(9):e0139141. doi: 10.1371/journal.pone.0139141. eCollection 2015.
8
Approach to diabetes management in patients with CVD.
Trends Cardiovasc Med. 2016 Feb;26(2):165-79. doi: 10.1016/j.tcm.2015.05.005. Epub 2015 May 21.
9
Type-2 diabetes increases autophagy in the human heart through promotion of Beclin-1 mediated pathway.
Int J Cardiol. 2016 Jan 1;202:13-20. doi: 10.1016/j.ijcard.2015.08.111. Epub 2015 Aug 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验